Long-term control of recalcitrant psoriasis with combination infliximab and methotrexate

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 415-416

  Warren, R B ^a   Brown, B C ^a   Carmichael, A J ^b   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; ETRETIN; ETRETINATE; FOLIC ACID; HYDROXYUREA; INFLIXIMAB; METHOTREXATE; PSORALEN;

ADULT; CASE REPORT; CHRONIC KIDNEY DISEASE; CONTINUOUS INFUSION; DISABILITY; DRUG APPROVAL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS SEVERITY INDEX; RELAPSE; SCORING SYSTEM; SKIN DISEASE; VISUAL ANALOG SCALE;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; HUMANS; MALE; METHOTREXATE; PSORIASIS;

EID: 62449205652     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02946.x     Document Type: Letter

References (5)

1. National Institute for Health and Clinical Excellence. Infliximab for the Treatment of Adults with Psoriasis. http://www.nice.org.UK/TA134 (accessed January 2008).
2. Reich K, Nestle FO, Papp K et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005 366 : 1367 74.
3. Kirby B, Marsland AM, Carmichael AJ et al. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate. Clin Exp Dermatol 2001 26 : 27 9.
4. Klotz U, Teml A, Schwab M. Clinical pharmacokinetics and use of infliximab. Clin Pharmacokinet 2007 46 : 645 60.
5. Menter A, Feldman SR, Weinstein GD et al. A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol 2007 56 : 31 5.